Illumina urges court to overturn DNA patent verdict

06-06-2022

Illumina urges court to overturn DNA patent verdict

Michael Vi / Shutterstock.com

Biotech company Illumina has asked a Delaware court to overturn a finding that it willfully infringed two DNA sequencing patents and must pay $334 million in damages.


Illumina, Complete Genomics, patent infringement, patents, DNA, retrial, BGI Genomics

LSIPR